Veterinary ICU Monitoring: Pain Assessment and Management

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Critically ill veterinary patients present unique challenges for pain assessment due to altered mentation, cardiovascular instability, and multisystem disease, necessitating systematic, scheduled evaluations rather than ad hoc observations.
• Composite pain scales, combining behavioral and physiological parameters, are crucial for sensitive pain detection, but require species-specific validation and consistent application by trained personnel to mitigate inter-observer variability.
• Physiologic variables (heart rate, respiratory rate, blood pressure) are unreliable standalone pain indicators in the ICU; their interpretation must focus on trends in response to handling and analgesia, accounting for confounding factors like drugs and disease states.
• The analgesic response trial, where a decrease in pain score following analgesic administration confirms pain as the cause of observed signs, is particularly valuable in non-communicative ICU patients and serves a dual diagnostic and therapeutic purpose.
• Multimodal analgesia, integrating opioids, NSAIDs, local anesthetics, and adjunctive agents, is essential to reduce opioid-related adverse effects (respiratory depression, ileus) and improve pain control by targeting different pain pathways.
• Differentiating sedation from analgesia is critical; a quiet patient may still be in pain, requiring careful assessment of behavioral output versus nociceptive input, especially when using drugs like alpha-2 agonists or opioids.

Pain assessment in the critically ill veterinary patient presents a distinct clinical challenge. The ICU population includes animals with altered mentation, cardiovascular instability, respiratory compromise, and multisystem disease, all of which can obscure or mimic pain-related behaviors. This article provides a framework for systematic pain recognition and analgesic decision-making in dogs, cats, horses, and other species managed in intensive care settings. It is written for practicing veterinarians who require a structured approach to pain scoring, interpretation of physiologic and behavioral parameters, and integration of analgesic principles into the broader monitoring plan. The focus is on assessment methodology and analgesic strategy, not on specific drug protocols or dosing.

At a Glance

The Physiology of Pain in Critical Illness

Pain in the ICU patient is not a single phenomenon. It arises from tissue injury, inflammation, surgical incisions, indwelling devices, and the disease process itself. Nociceptive input undergoes modulation at the spinal cord and supraspinal levels, and critical illness alters these pathways. Hypoxia, acidosis, electrolyte disturbances, and systemic inflammation can amplify central sensitization, lowering the threshold for pain perception. Conversely, severe neurologic depression or the administration of sedative drugs may suppress the behavioral output of pain while the nociceptive input continues.

The relationship between nociception and pain behavior is therefore nonlinear in the critically ill. A patient with peritonitis and septic shock may show minimal movement or vocalization because it lacks the energy or neurologic capacity to express pain. The absence of obvious pain behavior does not indicate the absence of pain. This principle underlies the recommendation for scheduled, systematic pain assessment instead of ad hoc evaluation when the patient appears distressed.

Pain Assessment Tools and Their Limitations

Composite Pain Scales

Composite pain scales combine multiple behavioral and physiologic parameters into a single numerical score. They were developed to address the poor sensitivity of simple descriptive scales and visual analogue scales, which rely on a single global judgment by the observer. In horses, composite scales have been developed and evaluated for specific conditions including acute colic, post-abdominal surgery, laminitis, and post-castration pain, as described in a narrative review of systematic pain assessment in equine patients. The review notes that scale validation is condition-specific and that a scale validated for one pain state may not perform adequately in another.

For small animals, composite scales typically include items such as posture, mobility, response to palpation, vocalization, and interaction with the environment. The observer assigns a subscore to each item and sums the total. These scales require training to apply consistently. Inter-observer reliability varies, and the same patient may receive different scores from different assessors. In the ICU, where multiple clinicians and technicians may assess the same patient across a 24-hour period, this variability is a practical concern. Standardizing the assessor where possible, or providing structured training, improves consistency.

Grimace Scales

Facial expression scoring has gained attention as a pain assessment method. The Mouse Grimace Scale and similar tools for other species score changes in orbital tightening, ear position, and whisker movement. In experimental sepsis, grimace scores increased in a severity-dependent manner alongside other clinical scoring systems, supporting their use as surrogate markers of disease progression. However, grimace scales capture a narrow window of the pain response and may be less useful in patients with facial trauma, neurologic disease, or severe systemic illness that alters facial muscle tone. They are best used as one component of a multimodal assessment.

Physiologic Parameters

Heart rate, respiratory rate, blood pressure, and pupil size change with acute pain through sympathetic activation. These parameters are attractive because they are objective and continuously measurable. Their specificity is poor in the ICU. Tachycardia may reflect hypovolemia, fever, anxiety, or drug effects. Hypertension may be iatrogenic from vasopressor infusion. A patient receiving an opioid infusion may have a lower heart rate despite significant pain. Physiologic variables should therefore be interpreted as trends in response to analgesic administration and handling, not as standalone pain indicators.

The Assessment Protocol

A structured assessment protocol separates observation from interaction. The first step is undisturbed observation. The patient is observed from a distance for posture, movement, respiratory pattern, and interaction with the environment. A horse with colic may paw, roll, or repeatedly look at its flank. A dog with pancreatitis may adopt a prayer position or resist lying down. A cat with abdominal pain may be tucked, tense, and reluctant to move.

The second step is interactive assessment. The observer approaches the patient, notes response to the presence of a person, and then gently palpates the suspected painful region. Response is graded as none, mild, moderate, or severe based on withdrawal, guarding, vocalization, or attempts to bite. This step requires knowledge of the patient's baseline temperament. A fractious cat may react to any touch, while a depressed dog may not react even to significant pain.

The third step is the analgesic response trial. When pain is suspected but not confirmed, an analgesic is administered and the assessment is repeated within the expected onset window. A decrease in pain score supports the diagnosis of pain. This trial is particularly valuable in the ICU, where many patients cannot communicate pain through typical behaviors. The trial also serves a therapeutic purpose, since the patient receives analgesia while the diagnostic question is answered.

Challenges Specific to the ICU

The Obtunded or Comatose Patient

Patients with severe neurologic depression present the greatest assessment difficulty. They may not respond to palpation, yet they may still experience pain. In these patients, physiologic parameters and response to noxious stimulation are the available tools, but both are unreliable. The clinician must weigh the risk of under-treating pain against the risk of respiratory depression or hypotension from analgesic drugs. A reasonable approach is to assume pain is present when the underlying condition is known to be painful, and to titrate analgesia to physiologic stability instead of to behavioral response.

Species Variation

Pain assessment tools are species-specific. A scale validated in dogs cannot be assumed to work in cats, and neither can be applied to rabbits, birds, or reptiles. The equine literature illustrates this point clearly: composite pain scales developed for horses with colic have undergone validation studies specific to that condition, and their translation to other pain states or other species is not automatic. In zoo animals, welfare assessment programs increasingly use species-specific tools, but the evidence base for many taxa remains limited. The clinician should select the best available tool for the species and condition, acknowledge its limitations, and combine it with clinical judgment.

The Influence of Analgesic and Sedative Drugs

Opioids, alpha-2 agonists, and other analgesic drugs alter the very parameters used to assess pain. A patient receiving dexmedetomidine will have a lower heart rate and may appear sedated, making pain scoring difficult. Conversely, inadequate analgesia may manifest as agitation that is mistaken for the side effects of the drug. The assessment protocol must account for the drug profile of each patient. This requires close communication between the prescribing clinician and the nursing staff performing the assessments, and a shared understanding of what each parameter means in the context of the current drug regimen.

The Analgesic Decision Framework

Pain scoring in the ICU serves one primary purpose: to determine whether analgesia is adequate, insufficient, or excessive. The decision to escalate, maintain, or taper analgesic therapy should follow a structured sequence that integrates the pain score, the physiologic trajectory, and the anticipated nociceptive load of the underlying disease process.

Begin with a baseline score at admission or at the time of initiating mechanical ventilation, then reassess at fixed intervals. For patients with an indwelling arterial catheter or continuous electrocardiographic monitoring, the score can be interpreted alongside heart rate and blood pressure trends. A rising composite pain score with concurrent tachycardia and hypertension supports dose escalation. A stable score with progressive hypotension or bradycardia should prompt evaluation for drug accumulation, hypovolemia, or sepsis instead of additional analgesia.

The analgesic ladder for ICU patients proceeds from multimodal background analgesia to escalating interventions. For patients with mild pain, a single agent targeting the predominant pain pathway may suffice. Moderate pain warrants combination therapy using agents with different mechanisms, such as an opioid with a nonsteroidal anti-inflammatory drug or a local anesthetic technique. Severe pain, or pain refractory to combination therapy, requires opioid dose escalation, continuous rate infusions, or regional anesthetic techniques where feasible.

The choice of first-line agent depends on the pain type. Somatic pain from surgical incisions or trauma responds to opioids and nonsteroidal anti-inflammatory drugs. Visceral pain from peritonitis or pancreatitis often benefits from opioids with visceral activity, such as methadone or buprenorphine, combined with adjunctive agents. Neuropathic pain, which may accompany spinal cord injury or severe nerve trauma, responds poorly to opioids alone and requires agents such as gabapentinoids or ketamine. The clinician must match the drug class to the suspected pain mechanism instead of defaulting to a single opioid for all patients.

Reassessment frequency should mirror the pharmacokinetics of the drugs used. After a bolus of a short-acting opioid, reassess within 15 to 30 minutes. After a dose adjustment of a continuous infusion, allow two to three elimination half-lives before judging efficacy. After a regional block, reassess at the expected duration of action of the local anesthetic. Documenting the time of administration and the time of reassessment prevents premature dose escalation that leads to drug accumulation.

Multimodal Analgesia in the Critically Ill Patient

Multimodal analgesia, the concurrent use of agents from different drug classes, reduces the total opioid dose required and attenuates opioid-related adverse effects. In the ICU, this strategy is particularly valuable because opioid-induced respiratory depression, ileus, and sedation complicate weaning from mechanical ventilation and delay enteral nutrition.

The components of a multimodal plan include opioids for moderate to severe pain, nonsteroidal anti-inflammatory drugs or other cyclooxygenase inhibitors for inflammatory pain, local anesthetics delivered by infiltration, nerve blocks, or epidural catheter, and adjunctive agents such as ketamine, lidocaine infusions, or gabapentinoids. Each component contributes to analgesia through a distinct mechanism, and the combination produces additive or synergistic effects.

Patient status modifies the selection of components. Nonsteroidal anti-inflammatory drugs are contraindicated in patients with renal dysfunction, gastrointestinal ulceration, or coagulopathy, all of which occur commonly in critically ill animals. Ketamine provides analgesia and reduces central sensitization but may cause dysphoria or hypertension at higher doses. Lidocaine infusions are useful for visceral and neuropathic pain but require electrocardiographic monitoring and dose adjustment in hepatic disease. Epidural analgesia provides excellent somatic and visceral coverage for caudal abdominal or pelvic procedures but is contraindicated in coagulopathic or septic patients.

The route of administration also requires consideration. Critically ill patients frequently have reduced gastrointestinal perfusion, making oral or enteral drug absorption unpredictable. Transdermal patches have a slow onset and variable absorption in hypothermic or vasoconstricted patients. Intravenous administration provides reliable delivery and rapid titration, and it remains the preferred route for acute pain management in the ICU. Intramuscular injections should be avoided in patients with coagulopathy or reduced muscle perfusion.

The Pain Scoring System

The following composite scoring system is designed for serial use in the ICU. It integrates behavioral observation, response to handling, and physiologic parameters. Each domain is scored from 0 to 3, and the total score ranges from 0 to 12. A score of 0 to 2 indicates minimal pain, 3 to 5 indicates mild to moderate pain, 6 to 8 indicates moderate to severe pain, and 9 to 12 indicates severe pain requiring immediate intervention.

The score should be recorded at each assessment interval on the ICU flow sheet, along with the time of last analgesic administration. Trending the score over time is more informative than a single value. A patient whose score rises from 2 to 5 over four hours despite stable therapy requires reassessment of the analgesic plan. A patient whose score falls from 8 to 3 after a dose adjustment demonstrates appropriate response.

This system is adapted from principles described in the equine pain assessment literature, where composite scales have been validated for detecting pain in colic and postoperative patients de Grauw and van Loon, systematic pain assessment in horses. The same principles of structured behavioral observation and physiologic integration apply across species, although the specific behaviors scored must be adapted to the species under assessment.

The Analgesic Decision Tree

The decision tree below provides a structured approach to analgesic adjustment in the ICU patient.

Step 1: Score the patient. Apply the composite scoring system at the scheduled interval. Record the score and the time since last analgesic administration.

Step 2: Interpret the score in context. A score of 3 to 5 in a patient who received a short-acting opioid two hours ago indicates inadequate coverage. The same score in a patient who received a long-acting opioid 30 minutes ago may reflect incomplete onset. Consider the drug, the dose, the route, and the time course before adjusting.

Step 3: Rule out non-pain causes of elevated scores. Tachycardia, tachypnea, and behavioral changes may reflect hypovolemia, hypoxia, hyperthermia, anxiety, or delirium. If the score is elevated but the clinical picture suggests a non-pain cause, address that cause before escalating analgesia.

Step 4: Escalate according to the ladder. For mild pain, add a non-opioid adjunct or increase the interval of the existing agent. For moderate pain, add a second drug class or increase the opioid dose. For severe pain, initiate a continuous opioid infusion, add ketamine or lidocaine, or perform a regional block.

Step 5: Reassess within the appropriate interval. Short-acting agents require reassessment within 15 to 30 minutes. Continuous infusions require reassessment after two to three half-lives. Document the new score and the response.

Step 6: Taper when the nociceptive load decreases. As the underlying disease resolves, reduce the analgesic dose by 20 to 30 percent per reassessment interval while monitoring the score. A rising score during tapering indicates that the reduction was premature.

Documentation and Communication

Pain scores are only useful if they are recorded, trended, and communicated. The ICU flow sheet should include a dedicated pain score column with the time of assessment and the time of last analgesic administration. The score should be incorporated into the daily patient rounds, alongside the fluid balance, respiratory status, and neurologic status.

Standardized assessment tools improve inter-observer reliability. When multiple clinicians assess the same patient across a 24-hour period, the use of a defined scoring system reduces subjective variation. This is particularly important in teaching hospitals and referral practices where multiple clinicians share patient care. The same principle applies in zoo and production animal settings, where standardized welfare assessment tools improve consistency across observers Jones et al, welfare assessment tools in zoos.

Documentation should also record the analgesic drugs administered, the route, the dose, the response, and any adverse effects. This record supports subsequent dose adjustments and provides a basis for retrospective review of analgesic quality. In patients with prolonged ICU stays, the cumulative opioid dose should be reviewed daily to identify patients at risk of tolerance or withdrawal.

The assessment protocol should be adapted to the species and the clinical context. In horses, the available pain scales vary in their sensitivity and validation status, and the clinician must select a scale appropriate to the pain state being assessed de Grauw and van Loon, systematic pain assessment in horses. In small mammals and exotic species, the grimace scales and clinical assessment scores developed for laboratory rodents provide a framework that can be adapted for clinical use. In production animals, objective scoring of behavior and handling responses supports welfare assessment at the group level. The underlying principle remains consistent: structured, repeated, and documented assessment drives rational analgesic therapy.

Recognized Complications and Failure Modes

Analgesic therapy in the ICU fails through predictable pathways. The most common is underdosing driven by fear of cardiovascular depression. Hypotension after an opioid bolus is often attributed to the drug when hypovolemia, sepsis, or myocardial dysfunction is the true cause. The discriminating check is volume status assessment using serial lactate, central venous pressure, or focused ultrasound, as described in abdominal and thoracic focused assessment with sonography for trauma and monitoring in small animals. A fluid-responsive patient will tolerate opioid titration once preload is restored.

Oversedation is the mirror-image failure. Accumulation of opioids or ketamine in patients with hepatic or renal dysfunction produces prolonged recumbency, hypoventilation, and ileus. Capnography and serial sedation scoring distinguish drug effect from deteriorating intracranial compliance or sepsis-associated encephalopathy. When sedation scores rise out of proportion to the analgesic dose, review organ function and reduce dosing intervals instead of adding reversal agents reflexively.

Dysphoria and paradoxical agitation occur with certain opioids, particularly in cats and in dogs with head trauma. The observation of vocalisation, pacing, and apparent distress immediately after administration is frequently misread as inadequate analgesia, prompting another dose. The correct response is to verify the pain score, examine for escalating physiologic parameters, and consider switching drug class or adding a dissociative agent.

Withdrawal syndromes appear when continuous infusions are stopped abruptly after more than 48 hours. Tachycardia, hypertension, piloerection, and restlessness emerge within hours. Tapering protocols and a structured weaning plan prevent this complication. The RECOVER initiative veterinary CPR guidelines note that cardiovascular instability in the post-arrest period complicates analgesic titration, and the same principle applies to any hemodynamically fragile patient: drug withdrawal must be managed as deliberately as drug administration.

Common Errors and Corrective Actions

Less experienced clinicians commonly score pain only at rest. Movement-evoked pain is more sensitive for detecting inadequate analgesia and should be assessed at each nursing intervention. Another frequent error is scoring pain and sedation as independent variables. They are coupled. A heavily sedated patient cannot express pain behavior, so a low pain score in a deeply sedated patient does not justify reducing analgesia. The reverse also holds: a painful patient may appear agitated, and the agitation is sometimes treated with additional sedation instead of analgesia.

Students often over-rely on a single physiologic parameter, particularly heart rate. Tachycardia has many causes in the critically ill patient, and bradycardia does not exclude severe pain in patients with increased vagal tone or on certain drugs. The corrective action is to use composite assessment, integrating behavior, physiology, and response to handling, and to document the trend instead of the single value.

Evidence Limitations and Contested Areas

The evidence base for ICU pain assessment is uneven across species. Equine pain scales are comparatively well developed, with composite scales and grimace tools validated for colic and post-operative pain, as reviewed in systematic pain assessment in horses. Small animal scales exist but validation studies are fewer, and most were developed for acute procedural pain instead of the complex, prolonged pain of critical illness. The MSD Veterinary Manual notes that extrapolation of pain scales between species and between clinical contexts is unreliable, and this limitation is most acute in the ICU where concurrent disease, drugs, and mechanical ventilation confound behavioral expression.

Expert opinion differs on several points. Whether to treat pain aggressively in hypotensive patients remains contested. Some argue that analgesia-induced vasodilation is manageable with fluids and vasopressors, others defer opioids until perfusion is restored. The safer position is to treat hypovolemia first, then titrate analgesia with close monitoring. There is also disagreement on the role of continuous rate infusions versus intermittent boluses. Infusions provide steady analgesia but complicate neurologic assessment and require dedicated vascular access. Boluses allow intermittent examination but produce peaks and troughs in both analgesia and sedation.

Objective sensor technologies for pain detection remain investigational. A systematic review of commercially available sensor technologies for dairy cattle found that only a small fraction of marketed devices had external validation, and validated traits concerned activity, feeding, and behavior instead of pain specifically. Similar limitations apply to companion animal monitoring. Automated pain detection is not yet ready for clinical ICU use.

Referral, Consultation, and Reporting

Referral to a specialist service is warranted when pain remains uncontrolled after two analgesic escalations, when the patient requires mechanical ventilation and analgesic titration becomes inseparable from ventilatory management, or when the cause of pain is uncertain and diagnostic imaging or surgical exploration is needed. Veterinary anesthesiologists and criticalists can provide locoregional techniques, advanced monitoring, and expertise in weaning from sedation.

Laboratory involvement is indicated when coagulopathy complicates epidural catheter placement, when suspected sepsis requires culture and sensitivity to guide antimicrobial selection alongside analgesia, or when organ dysfunction alters drug clearance and therapeutic drug monitoring is available.

Regulatory reporting obligations vary by jurisdiction. The WOAH terrestrial animal health code sets international standards for animal welfare in research and production settings, and the AVMA practice resources provide guidance on professional obligations. In production animal practice, analgesic protocols must comply with withdrawal periods, and in research settings, institutional animal care committees require documented pain assessment and humane endpoints. When analgesic failure results in unrelieved suffering that cannot be managed within available resources, euthanasia must be considered a legitimate therapeutic option instead of a failure of care.

Frequently Asked Questions

How Should I Prioritize Pain Scoring When Staff Time and Caseload Are Limited?

Integrate pain scoring into existing vital sign rounds instead of treating it as a separate task. Assign a single nurse or technician to score all ICU patients at each assessment interval, using the same validated scale for each species. If full composite scoring is impractical, use a two-step screen: a grimace scale or behavioral observation first, then a composite scale only for patients with abnormal results. Document the score directly on the treatment sheet beside temperature and heart rate. When staffing is critically short, prioritize scoring for postoperative patients, those with known painful conditions, and any patient receiving opioids, since these groups carry the highest risk of unrecognized pain. Systematic pain assessment in horses demonstrates that even brief structured observations outperform unstructured assessment.

What Do I Do When the Patient Cannot Be Safely Handled for a Full Pain Assessment?

Use remote observation before any handling. Record respiratory pattern, posture, willingness to move, and facial expression from outside the cage or stall. Video recording allows repeated scoring without disturbing the patient and permits comparison over time. For patients that are hemodynamically unstable or at risk of fracture, scoring must never require repositioning. In these cases, rely on grimace scales and physiologic parameters alone, and document the limitation in the medical record. The Murine Sepsis Score and Mouse Grimace Scale comparison shows that grimace-based scoring can track disease severity even when animals cannot be manipulated, supporting the use of facial expression as a primary tool in non-handleable patients.

How Should Pain Assessment Differ for ICU Patients That Are Not Dogs or Cats?

Species-specific scales are essential. Horses have validated composite pain scales and grimace scales for colic and postoperative pain, but these tools vary in sensitivity and reliability across pain states, so select the scale validated for the specific condition. Systematic pain assessment in horses highlights that a scale validated for laminitis may not transfer directly to post-castration pain. For cattle and small ruminants, use behavioral indicators such as posture, weight shifting, and vocalization, but recognize that prey species mask pain. Zoo and wildlife patients may require taxon-specific tools, and welfare assessment approaches in zoos emphasize that generic scoring schemes often miss species-relevant pain behaviors. Consult species-specific references before scoring any non-domestic patient.

How Do I Document Pain Scores So That Trends Are Actually Useful?

Record the raw score, the scale used, the time, and the observer's initials in a dedicated pain column on the flow sheet. Never record only a descriptor such as "comfortable" without the numeric score. Plot serial scores graphically so that escalation or weaning decisions are based on trajectory, not single readings. Note any analgesic drugs given between scores, since opioid administration changes the interpretation of subsequent assessments. Include a comment when the patient could not be handled or when sedation confounds scoring. This documentation supports analgesic adjustments during rounds and provides a defensible record if complications arise. The RECOVER CPR guidelines model structured documentation for post-arrest patients, where serial neurologic and pain assessments guide ongoing care decisions.

How Should I Explain Pain Scoring to an Owner Who Is Visiting the ICU?

Use concrete language tied to what the owner can observe. Explain that the team assigns a numeric score based on posture, facial expression, response to touch, and interaction with the environment, and that the score is tracked over time to judge whether analgesia is adequate. Show the owner the scale and point out the specific behaviors being monitored in their pet. Explain that some patients hide pain, so the team relies on structured scoring instead of waiting for obvious signs. Reassure the owner that scoring is performed at regular intervals and that scores directly drive medication adjustments. Avoid promising that the patient will be pain-free, since the goal is controlled pain that does not impair recovery.

What Are the Minimum Standards for Pain Monitoring in a Practice That Lacks Advanced Monitoring Equipment?

A validated grimace scale and a simple numerical rating scale require no equipment beyond the printed scoring sheet. These tools provide adequate monitoring for most ICU patients. Physiologic parameters such as heart rate, respiratory rate, and blood pressure should be recorded concurrently, but interpret them cautiously since they are influenced by sedation, shock, and concurrent disease. If the practice has no validated scale for the species being treated, use the MSD Veterinary Manual species-specific guidance on pain recognition. For production animals, objective scoring methods used at slaughter plants demonstrate that simple, standardized behavioral observations can reliably identify animals in distress without any instrumentation.

Related Clinical & Scientific Guides

• Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach
• Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care
• Fluid Therapy Guidelines for Dogs and Cats: A Practical Update

References and Further Reading

• Systematic pain assessment in horses.. 2016.
• Abdominal and thoracic focused assessment with sonography for trauma, triage, and monitoring in small animals.. 2011.
• Objective scoring of animal handling and stunning practices at slaughter plants.. 1998.
• Welfare Assessment Tools in Zoos: From Theory to Practice.. 2022.
• Body temperature and mouse scoring systems as surrogate markers of death in cecal ligation and puncture sepsis.. 2018.
• A Systematic Review on Commercially Available and Validated Sensor Technologies for Welfare Assessment of Dairy Cattle.. 2021.
• RECOVER Initiative Veterinary CPR Guidelines. Veterinary Emergency and Critical Care Society.
• AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats. AAHA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Veterinary ICU Monitoring: Coagulation Assessment
• Invasive Hemodynamic Monitoring in the Veterinary ICU
• Veterinary ICU Monitoring: Electrolyte and Acid-Base Balance
• Veterinary ICU Monitoring: Parameters and Frequency for Critical Patients
• Veterinary Blood Transfusion: Administration and Monitoring

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.